Literature DB >> 4340370

Studies on the interaction of warfarin and clofibrate in man.

R A O'Reilly, M A Sahud, A J Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4340370

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN： 0340-5338


× No keyword cloud information.
  9 in total

Review 1.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Ezetimibe enhances and stabilizes anticoagulant effect of warfarin.

Authors:  Takehiro Hashikata; Minako Yamaoka-Tojo; Ryota Kakizaki; Teruyoshi Nemoto; Kazuhiro Fujiyoshi; Sayaka Namba; Lisa Kitasato; Takuya Hashimoto; Shunsuke Ishii; Ryo Kameda; Takao Shimohama; Taiki Tojo; Junya Ako
Journal:  Heart Vessels       Date:  2016-04-06       Impact factor: 2.037

3.  Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.

Authors:  T D Bjornsson; P J Meffin; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

4.  Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.

Authors:  J P Tillement; C Mattei; R Zini
Journal:  Experientia       Date:  1974-05-15

Review 5.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

Review 6.  Drug interactions with warfarin.

Authors:  M J Serlin; A M Breckenridge
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

7.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

Review 8.  Drug interactions of lipid-altering drugs.

Authors:  H E Bays; C A Dujovne
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 9.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.